Russell 2000 ETF (IWM) lagged the larger S&P 500 ETF (SPY) by more than 10 percentage points since the end of the third quarter of 2018 as investors first worried over the possible...
Keep Reading →
December 9 - Hedge Funds, News - Comments
Billionaire hedge fund managers such as David Abrams, Steve Cohen and Stan Druckenmiller can generate millions or even billions of dollars every year by pinning down high-potential...
Keep Reading →
November 6 - Hedge Funds, News - Comments
While the market driven by short-term sentiment influenced by the accomodative interest rate environment in the US, increasing oil prices and optimism towards the resolution of...
Keep Reading →
June 26 - Hedge Funds, News - Comments
Concerns over rising interest rates and expected further rate increases have hit several stocks hard since the end of the third quarter.
Keep Reading →
December 12 - Hedge Funds, News - Comments
The elite funds run by legendary investors such as Dan Loeb and David Tepper make hundreds of millions of dollars for themselves and their investors by spending enormous resources...
Keep Reading →
December 8 - Hedge Funds, News - Comments
There are plenty of opportunities to invest in healthcare stocks, as there are thousands of companies, ranging from big and well-established pharmaceuticals that also pay substantial...
Keep Reading →
March 14 - Hedge Funds, News - Comments
Investing in cheap stocks can be risky and inexperienced investors are usually advised to stay clear of them, even though many new investors go straight to cheap stocks hoping...
Keep Reading →
March 5 - Hedge Funds, News - Comments
Penny stocks are usually defined as shares of small companies that trade under $1 per share, although the SEC defines a penny stock as a security that trades under $5 per share...
Keep Reading →
September 1 - Lists, News - Comments
"Stocks rose on Wall Street on Thursday, capping a wave of declines in major world equity markets triggered by uncertainty over U.S.
Keep Reading →
May 18 - Commodities, Futures/Forex, Gold, Market Movers, News, Tech - Comments
There are several ways to beat the market, and investing in small cap stocks has historically been one of them.
Keep Reading →
November 26 - Hedge Funds, News - Comments
The healthcare sector has witnessed a significant correction in the last 15 months, with many prominent names in the industry losing a noteworthy chunk of their market capitalization...
Keep Reading →
October 8 - Hedge Funds, News - Comments
As we noted last week, the close of the third quarter and the start of the final quarter of the year is when volume really starts to pick up in wider financial asset markets, ...
Keep Reading →
September 13 - News, Stock Analysis - Comments
Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN) is a $1.09 billion market cap biotech company focused on solutions for infectious diseases.
Keep Reading →
May 23 - Hedge Funds, News - Comments
When it comes to the risk-reward ratio, there are very few sectors which can match up to healthcare.
Keep Reading →
March 24 - Hedge Funds, News - Comments
Peter Kolchinsky founded RA Capital Management in 2001 and focuses mainly on healthcare stocks.
Keep Reading →
February 25 - Hedge Funds, News - Comments
The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data.
Keep Reading →
December 2 - Hedge Funds, News - Comments
Investing in the healthcare sector can be tricky, especially if you're looking for high returns and want to invest in clinical-stage companies, which represent an above-average...
Keep Reading →
September 16 - Hedge Funds, News - Comments
Peter Kolchinsky's RA Capital Management recently filed its 13F with the SEC for the reporting period of June 30.
Keep Reading →
August 15 - Hedge Fund Analysis, Hedge Funds, News - Comments
Mere months after closing its previously held stake in the company, Steve Cohen’s Point72 Asset Management appears to be more bullish than ever on Achillion Pharmaceuticals, ...
Keep Reading →
May 31 - Hedge Funds, News - Comments
CIG Wireless Corp (OTCBB:CIGW), an operator of wireless and broadcast communication towers in the United States, has issued approximately 1.25 million shares to Jeffrey Tannenbaum...
Keep Reading →
October 2 - Hedge Funds, News - Comments
RA Capital Management has continued the sale of Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN) shares.
Keep Reading →
September 29 - Hedge Funds, News - Comments
RA Capital Management, managed by Peter Kolchinsky, continues to unload its stake in Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN). In a new filing with the U.S.
Keep Reading →
September 24 - Hedge Funds, News - Comments
Peter Kolchinsky's RA Capital Management, in a new filing with the Securities and Exchange Commission, has disclosed the sale of around 1.70 million shares of Achillion Pharmaceuticals...
Keep Reading →
September 12 - Hedge Funds, News - Comments
In a new filing with the U.S.
Keep Reading →
September 4 - Hedge Funds, News - Comments
Some of Europe's most powerful hedge fund managers are sharply divided on the outlook for English soccer club Manchester United PLC (NYSE:MANU) -0.17%, whose share price has ...
Keep Reading →
August 28 - Hedge Funds - Comments
RA Capital Management, led by Peter Kolchinsky, disclosed in a newly amended filing with the U.S.
Keep Reading →
August 28 - Hedge Funds, News - Comments
RA Capital Management, managed by Peter Kolchinsky, has sold 800,000 shares of Achillion Pharmaceuticals Inc.
Keep Reading →
June 25 - Hedge Funds, News - Comments
Peter Kolchinsky's hedge fund, Ra Capital Management disclosed upping its position in Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN) some more.
Keep Reading →
November 22 - Hedge Funds, News - Comments
Peter Kolchinsky's, RA Capital Management solidified its position in Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN) even more today.
Keep Reading →
November 13 - Hedge Funds, News - Comments
Since the beginning of November, Peter Kolchinsky's RA Capital Management has informed the U.S.
Keep Reading →
November 12 - Hedge Funds, News - Comments
Peter Kolchinsky and his hedge fund, RA Capital Management, boosted their position in Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN) to 21.2%, a filing with the SEC showed.
Keep Reading →
November 1 - Hedge Funds, News - Comments
Peter Kolchinsky, Achillion Pharmaceuticals: This afternoon, Peter Kolchinsky and his hedge fund, RA Capital Management, strengthened their position in Achillion Pharmaceuticals...
Keep Reading →
October 16 - Hedge Funds, News - Comments
Outerwall, Pandora, Achillion, hedge funds: It’s no secret that at Insider Monkey, we track hedge funds (discover why here).
Keep Reading →
October 11 - Hedge Funds, News - Comments
RA Capital, Achillion Pharmaceuticals: In a 13G filing with the SEC, Peter Kolchinsky's RA Capital disclosed that it owns nearly 15% of infectious disease-focused biopharma player...
Keep Reading →
October 4 - Hedge Funds, News - Comments
To the average investor, there are tons of methods shareholders can use to monitor the equity markets.
Keep Reading →
September 5 - News - Comments
To many market players, hedge funds are perceived as delayed, old financial tools of a period lost to current times.
Keep Reading →
September 3 - News - Comments
To the average investor, there are dozens of indicators market participants can use to analyze their holdings.
Keep Reading →
August 30 - News - Comments
In today’s marketplace, there are tons of gauges market participants can use to track their holdings.
Keep Reading →
August 28 - News - Comments
Babe Ruth wasn't afraid to swing for the fences. That's how he became Major League Baseball's home run king for decades.
Keep Reading →
July 15 - News - Comments
Hepatitis C, caused by the hepatitis C virus (HCV), is an infectious disease affecting the liver.
Keep Reading →
July 10 - News - Comments
With the SPDR S&P Biotech Index up 20% over the trailing-12-month period, it's evident that investment dollars are willingly flowing into the biotech sector.
Keep Reading →
July 8 - News - Comments
Biotechnology's a volatile sector that can intimidate many investors, but it's also a landscape of stocks that can reward portfolios with giant gains.
Keep Reading →
June 17 - News - Comments
To most stock holders, hedge funds are seen as underperforming, old financial tools of years past.
Keep Reading →
June 3 - News - Comments
If you'd ask most shareholders, hedge funds are assumed to be slow, outdated investment tools of the past.
Keep Reading →
May 31 - News - Comments
With the SPDR S&P Biotech Index up 31% over the trailing-12-month period, it's evident that investment dollars are willingly flowing into the biotech sector.
Keep Reading →
April 27 - News - Comments
Is Clovis Oncology Inc (NASDAQ:CLVS) the right investment to pursue these days? The best stock pickers are taking a pessimistic view.
Keep Reading →
April 15 - News - Comments
According to most investors, hedge funds are perceived as worthless, old financial tools of years past.
Keep Reading →
April 8 - News - Comments
The Motley Fool's annual April Fools' Day joke this year focused on the "hugest bubble in history" that is set to explode.
Keep Reading →
April 6 - News - Comments
In the world of biotech investing, there are many companies to choose from.
Keep Reading →
April 3 - News - Comments
